Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 95

1.

[Recent advances of positron emission tomography and CT scan for the diagnosis of early cancer].

Kubota K, Matsuzawa T, Fujiwara T, Abe Y, Tada M, Ido T, Ito M, Hatazawa J.

Nihon Rinsho. 1989 May;47(5):1037-43. Japanese. No abstract available.

PMID:
2787422
[PubMed - indexed for MEDLINE]
2.

Imaging in lung cancer.

Sarinas PS, Chitkara RK, Rizk NW, Segall GM, Stark P.

Curr Opin Pulm Med. 1996 Jul;2(4):263-70. Review.

PMID:
9363150
[PubMed - indexed for MEDLINE]
3.

Improved radiologic staging of lung cancer with 2-[18F]-fluoro-2-deoxy-D-glucose-positron emission tomography and computed tomography registration.

Aquino SL, Asmuth JC, Alpert NM, Halpern EF, Fischman AJ.

J Comput Assist Tomogr. 2003 Jul-Aug;27(4):479-84.

PMID:
12886128
[PubMed - indexed for MEDLINE]
4.

Test performance of positron emission tomography and computed tomography for mediastinal staging in patients with non-small-cell lung cancer: a meta-analysis.

Gould MK, Kuschner WG, Rydzak CE, Maclean CC, Demas AN, Shigemitsu H, Chan JK, Owens DK.

Ann Intern Med. 2003 Dec 2;139(11):879-92. Review.

PMID:
14644890
[PubMed - indexed for MEDLINE]
5.

Diagnosis of the presence of lymph node metastasis and decision of operative indication using fluorodeoxyglucose-positron emission tomography and computed tomography in patients with primary lung cancer.

Toba H, Kondo K, Otsuka H, Takizawa H, Kenzaki K, Sakiyama S, Tangoku A.

J Med Invest. 2010 Aug;57(3-4):305-13.

PMID:
20847531
[PubMed - indexed for MEDLINE]
Free Article
6.

Mediastinal lymph node staging of non-small-cell lung cancer: a prospective comparison of computed tomography and positron emission tomography.

Scott WJ, Gobar LS, Terry JD, Dewan NA, Sunderland JJ.

J Thorac Cardiovasc Surg. 1996 Mar;111(3):642-8.

PMID:
8601980
[PubMed - indexed for MEDLINE]
7.

Point: Clinical stage IA non-small cell lung cancer determined by computed tomography and positron emission tomography is frequently not pathologic IA non-small cell lung cancer: the problem of understaging.

Stiles BM, Servais EL, Lee PC, Port JL, Paul S, Altorki NK.

J Thorac Cardiovasc Surg. 2009 Jan;137(1):13-9. doi: 10.1016/j.jtcvs.2008.09.045.

PMID:
19154893
[PubMed - indexed for MEDLINE]
8.

[Contribution of PET using FDG in the diagnosis of lung cancer--first results].

Rubinstein R, Breuer R, Chisin R.

Harefuah. 2001 Feb;140(2):100-3, 191. Hebrew.

PMID:
11242909
[PubMed - indexed for MEDLINE]
9.

The size of metastatic foci and lymph nodes yielding false-negative and false-positive lymph node staging with positron emission tomography in patients with lung cancer.

Nomori H, Watanabe K, Ohtsuka T, Naruke T, Suemasu K, Uno K.

J Thorac Cardiovasc Surg. 2004 Apr;127(4):1087-92.

PMID:
15052206
[PubMed - indexed for MEDLINE]
10.

Staging of non-small-cell lung cancer with integrated positron-emission tomography and computed tomography.

Lardinois D, Weder W, Hany TF, Kamel EM, Korom S, Seifert B, von Schulthess GK, Steinert HC.

N Engl J Med. 2003 Jun 19;348(25):2500-7.

PMID:
12815135
[PubMed - indexed for MEDLINE]
Free Article
11.

[Positron emission tomography in the evaluation of intrathoracic lymphatic extension of non-small cell bronchial cancer. A preliminary study of 30 patients].

Bury T, Corhay JL, Paulus P, Weber T, D'Harcour JB, Limet R, Rigo P, Radermecker MF.

Rev Mal Respir. 1996 Jul;13(3):281-6. French.

PMID:
8765921
[PubMed - indexed for MEDLINE]
12.

Endoscopic ultrasound-guided fine needle aspiration of mediastinal lymph node in patients with suspected lung cancer after positron emission tomography and computed tomography scans.

Eloubeidi MA, Cerfolio RJ, Chen VK, Desmond R, Syed S, Ojha B.

Ann Thorac Surg. 2005 Jan;79(1):263-8.

PMID:
15620955
[PubMed - indexed for MEDLINE]
13.

Diffusion-weighted magnetic resonance imaging can be used in place of positron emission tomography for N staging of non-small cell lung cancer with fewer false-positive results.

Nomori H, Mori T, Ikeda K, Kawanaka K, Shiraishi S, Katahira K, Yamashita Y.

J Thorac Cardiovasc Surg. 2008 Apr;135(4):816-22. doi: 10.1016/j.jtcvs.2007.10.035.

PMID:
18374761
[PubMed - indexed for MEDLINE]
14.

PET/CT for staging lung cancer: costly or cost-saving?

Buck AK, Herrmann K, Schreyögg J.

Eur J Nucl Med Mol Imaging. 2011 May;38(5):799-801. doi: 10.1007/s00259-011-1803-3. Epub 2011 Mar 26. No abstract available.

PMID:
21442260
[PubMed - indexed for MEDLINE]
15.

Dysgenetic hypoplastic kidney simulating metastatic lung carcinoma.

Huang CH, McGregor DH, Haltaufderhyde V, Victor F, VanVeldhuizen P.

Lung Cancer. 2006 Oct;54(1):125-9. Epub 2006 Aug 22.

PMID:
16930766
[PubMed - indexed for MEDLINE]
16.

Improvement of non-small-cell lung cancer staging by means of positron emission tomography.

Albes JM, Lietzenmayer R, Schott U, Schülen E, Wehrmann M, Ziemer G.

Thorac Cardiovasc Surg. 1999 Feb;47(1):42-7.

PMID:
10218620
[PubMed - indexed for MEDLINE]
17.

Positron emission tomography plus computed tomography for staging early lung cancer.

[No authors listed]

Ann Intern Med. 2009 Aug 18;151(4):I-21. Epub 2009 Jul 6. No abstract available.

PMID:
19581637
[PubMed - indexed for MEDLINE]
18.

Characterization of pulmonary nodules and mediastinal staging of bronchogenic carcinoma with F-18 fluorodeoxyglucose positron emission tomography.

Hagberg RC, Segall GM, Stark P, Burdon TA, Pompili MF.

Eur J Cardiothorac Surg. 1997 Jul;12(1):92-7.

PMID:
9262087
[PubMed - indexed for MEDLINE]
19.

[The role of (18)F-FDG DHC SPECT-CT in the diagnosis and staging for lung cancer].

Mao YS, He J, Zheng R, Lin L, Liu L, Cheng Z.

Zhonghua Zhong Liu Za Zhi. 2008 Dec;30(12):933-6. Chinese.

PMID:
19173997
[PubMed - indexed for MEDLINE]
20.

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk